Unmasking the ongoing challenge of equid herpesvirus- 1 (EHV-1): A comprehensive review.

Overview

• This research article provides a detailed review of equid herpesvirus-1 (EHV-1), a viral pathogen significantly affecting horses worldwide.
• It discusses the biology, pathophysiology, and challenges in controlling the spread of EHV-1, with a focus on its recent increased prevalence and severe strains causing neurological disease.

Introduction to Equid Herpesvirus-1 (EHV-1)

• EHV-1 is one of the several equid herpesviruses that infect horses and related species.
• It primarily causes respiratory illness in infected horses but is capable of systemic spread affecting other organs.
• Significant health issues linked to EHV-1 include:
  • Abortions in pregnant mares
  • Neurological conditions often collectively termed equid herpesviral myeloencephalopathy (EHM)

Biological Characteristics and Lifecycle

• EHV-1 can establish latency, meaning the virus can remain dormant within the host with very limited gene expression or viral activity.
• This latent state allows the virus to evade the host immune system and antiviral treatments.
• The virus can reactivate from latency at unpredictable times, leading to new outbreaks and transmission opportunities.
• Understanding the mechanisms of latency and reactivation is key to managing persistent infection and limiting virus spread.

Recent Developments in EHV-1 Strains and Pathogenesis

• There has been a notable increase in the incidence of EHM, a severe neurological disorder caused by specific, often more virulent, strains of EHV-1.
• EHM presents a significant health concern due to its potential to cause paralysis and death in affected horses.
• Advancements in viral biology techniques have shed light on how genetic variation in EHV-1 strains contributes to differences in virulence and disease presentation.
• Understanding these variations informs the development of diagnostic tests, vaccines, and treatment strategies.

Implications for Disease Management and Control

• The dynamic and unpredictable nature of EHV-1 spread complicates efforts to control outbreaks in equine populations globally.
• Effective control requires comprehensive knowledge of virus biology and the factors influencing latency, reactivation, and transmission.
• Current strategies may include:
  • Surveillance and rapid diagnosis during outbreaks
  • Vaccination programs, although vaccines have limitations particularly against neurological disease forms
  • Quarantine and biosecurity measures to limit virus spread
• This review emphasizes the necessity of continued research to inform practical action plans aimed at preventing the global dissemination of EHV-1 among horses.

Conclusion

• The review highlights EHV-1 as a persistent threat to horse health due to its ability to cause severe disease, enter latency, and reactivate unpredictably.
• Improved understanding of viral biology and current epidemiological trends are essential to devising better prevention and control measures.
• This comprehensive overview encourages stakeholders in equine health to integrate scientific advances into practical solutions combating EHV-1’s impact on the equine industry worldwide.